452343
Antimony
beads, ≤5 mm, low oxide, 99.999% trace metals basis
Synonym(s):
Antimony black, Antimony element, Stibium
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
Sb
CAS Number:
Molecular Weight:
121.76
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141704
EC Number:
231-146-5
MDL number:
assay
99.999% trace metals basis
form
beads
reaction suitability
core: antimony
resistance
41.7 μΩ-cm
particle size
≤5 mm
bp
1635 °C (lit.)
density
6.69 g/mL at 25 °C (lit.)
SMILES string
[Sb]
InChI
1S/Sb
InChI key
WATWJIUSRGPENY-UHFFFAOYSA-N
Application
Applied in the solid state synthesis of a Zintl phase, SrSn3Sb4, with an anionic channel framework of 30-membered rings.
Still not finding the right product?
Explore all of our products under Antimony
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jaime Soto et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56(9), 1255-1260 (2013-02-08)
Cutaneous leishmaniasis is an ultimately self-curing disease for which systemic therapy with pentavalent antimony (Sb) is effective but with side effects. We evaluated 2 local treatments, intralesional (IL) Sb and cryotherapy, for single lesions due to Bolivian Leishmania (v.) braziliensis
Jian Chen et al.
Chemosphere, 90(6), 1925-1932 (2012-11-15)
Coal is one of the major energy resources in China, with nearly half of produced Chinese coal used for power and heat generation. The large use of coal for power and heat generation in China may result in significant atmospheric
Joseph N Jarvis et al.
Current opinion in infectious diseases, 26(1), 1-9 (2012-12-12)
HIV infection profoundly impairs the immune mechanisms needed to control and clear Leishmania infection, and outcomes in patients with HIV-associated visceral leishmaniasis are poor. This review summarizes recent work describing the epidemiology, presentation and outcomes of HIV-associated visceral leishmaniasis and